About Us

About Us

Cancer Research
Nova Scotia is a cancer research leader, both nationally and internationally. Cancer Care Nova Scotia plays a significant role in its development as one of the fastest growing cancer research communities in the country.

Cancer Care Nova Scotia has established the Peggy Davison Cancer Research Scientist Award, worth $600,000, to help build an expert team in cancer health services research – ultimately improving outcomes for cancer patients. It also funds the Norah Stephen Oncology Scholar Awards, student research awards designed to foster an interest in the field of oncology. Each year, 12 awards of $5000 each are presented to students to pursue cancer-related research or clinical training and experience projects. To date, 80 students have received the award and 24 have continued on or have plans to continue on in the field of cancer.

Researchers at Dalhousie University are receiving $1.8 million over six years to develop and operate a training centre for cancer researchers, funded in part by Cancer Care Nova Scotia. The funding is improving the quality of cancer care and bringing significant economic benefit to Nova Scotia.

Atlantic Canada has the highest rates of cancer in Canada. The Atlantic Partnership for Tomorrow’s Health is a 30-year cancer prevention study that seeks to determine the impact of various Atlantic Canada-specific health and lifestyle factors on cancer risk. To learn more, visit www.atlanticpath.ca.

Atlantic Clinical Cancer Research Unit (ACCRU) is the oncology clinical trial unit, operated by Capital Health, in conjunction with Dalhousie University, since 1995. Current trial treatment options include chemotherapy, hormone therapy, radiation therapy and new molecular therapies, all of which are designed to compare treatments for best results and fewest side effects.